Prostatic Neoplasms Clinical Trials in San Francisco, California

3 studies are recruiting for prostatic neoplasms in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate or enzalutamide in participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) previously treated with one next-generation hormonal agen…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    San Francisco VA Health Care System ( Site 0093), San Francisco, California
    Locations
    330 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06136650 on ClinicalTrials.gov

  2. Prostate Active Surveillance Study

    The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This …

    Stage
    Not phased
    Ages
    21 and older
    Site
    Veterans Affairs San Francisco Health Care System, San Francisco, California
    Locations
    11 in total
    Run by
    University of Washington

    See if you can join NCT00756665 on ClinicalTrials.gov

  3. A Study of DM002 in Patients With Advanced Solid Tumors

    The goal of study： The study has two parts: Part 1 Dose Escalation and Part 2 Dose Expansion. In Part 1, a few participants will receive the lowest dose of study drug. The study team will make sure it is safe and tolerated before enrolling new participants at a higher dose of study drug. There will…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of California San Francisco Cancer Center, San Francisco, California
    Locations
    7 in total
    Run by
    Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

    See if you can join NCT06751329 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.